About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 317487, 7 pages
http://dx.doi.org/10.1155/2013/317487
Review Article

Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma

1Department of Surgery, University of Arizona, Tucson, AZ, USA
2The University of Arizona Cancer Center, Tucson, AZ, USA
3Division of Surgical Oncology, Department of Surgery, University of Arizona, P.O. Box 245131, Tucson, AZ 85724-5131, USA

Received 10 November 2012; Revised 8 January 2013; Accepted 10 January 2013

Academic Editor: Eleonore Fröhlich

Copyright © 2013 Jack Hannallah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Robbins, V. Kumar, A. K. Abbas, R. S. Cotran, and N. Fausto, Robbins and Cotran Pathologic Basis of Disease, WB Saunders, Philadelphia, Pa, USA, 2010.
  2. E. M. Sanders Jr., V. A. LiVolsi, J. Brierley, J. Shin, and G. W. Randolph, “An evidence-based review of poorly differentiated thyroid cancer,” World Journal of Surgery, vol. 31, no. 5, pp. 934–945, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Volante, P. Collini, Y. E. Nikiforov et al., “Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach,” American Journal of Surgical Pathology, vol. 31, no. 8, pp. 1256–1264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Volante, S. Landolfi, L. Chiusa et al., “Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients,” Cancer, vol. 100, no. 5, pp. 950–957, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sakamoto, N. Kasai, and H. Sugano, “Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas,” Cancer, vol. 52, no. 10, pp. 1849–1855, 1983. View at Scopus
  6. M. L. Carcangiu, G. Zampi, and J. Rosai, “Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans' ‘Wuchernde Struma‘,” American Journal of Surgical Pathology, vol. 8, no. 9, pp. 655–668, 1984. View at Scopus
  7. D. Hiltzik, D. L. Carlson, R. M. Tuttle et al., “Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients,” Cancer, vol. 106, no. 6, pp. 1286–1295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bongiovanni, P. M. Sadow, and W. C. Faquin, “Poorly differentiated thyroid carcinoma: a cytologic-histologic review,” Advances in Anatomic Pathology, vol. 16, no. 5, pp. 283–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bongiovanni and W. C. Faquin, “Poorly differentiated thyroid carcinoma,” in The Bethesda System For Reporting Thyroid Cytopathology, pp. 129–138, Springer, New York, NY, USA, 2010. View at Publisher · View at Google Scholar
  10. G. Garcia-Rostan and M. Sobrinho-Simões, “Poorly differentiated thyroid carcinoma: an evolving entity,” Diagnostic Histopathology, vol. 17, no. 3, pp. 114–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Carcangiu, G. Zampi, and A. Pupi, “Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy,” Cancer, vol. 55, no. 4, pp. 805–828, 1985. View at Scopus
  12. P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, and R. Celestino, “Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas,” Current Genomics, vol. 12, no. 8, pp. 609–617, 2011. View at Publisher · View at Google Scholar
  13. M. Bongiovanni, L. Bloom, J. F. Krane et al., “Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases,” Cancer Cytopathology, vol. 117, no. 3, pp. 185–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. N. Patel and A. R. Shaha, “Poorly differentiated and anaplastic thyroid cancer,” Cancer Control, vol. 13, no. 2, pp. 119–128, 2006. View at Scopus
  15. M. Pulcrano, H. Boukheris, M. Talbot et al., “Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification,” Thyroid, vol. 17, no. 7, pp. 639–646, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Nikiforov, P. W. Biddinger, and L. D. Thompson, Diagnostic Pathology and Molecular Genetics of the Thyroid, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009.
  17. A. S. Rocha, P. Soares, E. Fonseca, J. Cameselle-Teijeiro, M. C. Oliveira, and M. Sobrinho-Simões, “E-cadherin loss rather than β-catenin alterations is a common feature of poorly differentiated thyroid carcinomas,” Histopathology, vol. 42, no. 6, pp. 580–587, 2003. View at Publisher · View at Google Scholar
  18. Y. E. Nikiforov, “Thyroid carcinoma: molecular pathways and therapeutic targets,” Modern Pathology, vol. 21, no. 2, pp. S37–S43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Walczyk, A. Kowalska, and J. Sygut, “The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma)—own observations,” Endokrynologia Polska, vol. 61, no. 5, pp. 467–473, 2010. View at Scopus
  20. J. L. Hunt and V. A. LiVolsi, “Poorly differentiated and undifferentiated thyroid carcinomas,” in Molecular Pathology of Endocrine Diseases, vol. 3, pp. 95–101, Springer, New York, NY, USA, 2010. View at Publisher · View at Google Scholar
  21. S. Asioli, L. A. Erickson, A. Righi et al., “Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression,” Modern Pathology, vol. 23, no. 9, pp. 1269–1278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. N. Nikiforova and Y. E Nikiforov, “Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis,” Expert Review of Molecular Diagnostics, vol. 8, no. 1, pp. 83–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sobrinho-Simões, V. Máximo, A. S. Rocha et al., “Intragenic mutations in thyroid cancer,” Endocrinology & Metabolism Clinics of North America, vol. 37, no. 2, pp. 333–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. E. Nikiforov, “Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas,” Endocrine Pathology, vol. 15, no. 4, pp. 319–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. T. C. Chao, J. D. Lin, and M. F. Chen, “Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course,” World Journal of Surgery, vol. 28, no. 4, pp. 393–396, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. S. Jung, T. Y. Kim, K. W. Kim et al., “Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma,” Endocrine Journal, vol. 54, no. 2, pp. 265–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. W. Randolph and D. Kamani, “The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy,” Surgery, vol. 139, no. 3, pp. 357–362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. The American Joint Committee on Cancer (AJCC), TNM Classification to Define Thyroid Cancer.
  29. E. Grande, J. J. Díez, C. Zafon, and J. Capdevila, “Thyroid cancer: molecular aspects and new therapeutic strategies,” Journal of Thyroid Research, vol. 2012, Article ID 847108, 10 pages, 2012. View at Publisher · View at Google Scholar
  30. W. Wang, S. M. Larson, M. Fazzari et al., “Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 3, pp. 1107–1113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ito, M. Hirokawa, T. Higashiyama et al., “Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination,” World Journal of Surgery, vol. 31, no. 7, pp. 1417–1424, 2007. View at Publisher · View at Google Scholar · View at Scopus